The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
The Role of Vimentin Intermediate Filaments in the Progression of Lung Cancer
Open accessAbstract
There is an accumulation of evidence in the literature demonstrating the integral role of vimentin intermediate filaments (IFs) in the progression of lung cancers. Vimentin IF proteins have been implicated in many aspects of cancer initiation and progression, including tumorigenesis, epithelial-to-mesenchymal transition (EMT), and the metastatic spread of cancer. Specifically, vimentin IFs have been recognized as an essential component regulating EMT, major signal transduction pathways involved in EMT and tumor progression, cell migration and invasion, the positioning and anchorage of organelles, such as mitochondria, and cell-cell and cell-substrate adhesion. In tumorgenesis, vimentin forms a complex with 14-3-3 and beclin 1 to inhibit autophagy via an AKT-dependent mechanism. Vimentin is a canonical marker of EMT, and recent evidence has shown it to be an important regulator of cellular motility. Transcriptional regulation of vimentin through hypoxia-inducible factor-1 may be a potential driver of EMT. Finally, vimentin regulates 14-3-3 complexes and controls various intracellular signaling and cell cycle control pathways by depleting the availability of free 14-3-3. There are many exciting advances in our understanding of the complex role of vimentin IFs in cancer, pointing to the key role vimentin IFs may play in tumor progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Tumor Metastasis: Molecular Insights and Evolving Paradigms
Valastyan, S., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.09.024 · Cited by 4,011
Vimentin in cancer and its potential as a molecular target for cancer therapy
Satelli, A., & Li, S. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0735-1 · Cited by 1,557
INTERMEDIATE FILAMENTS: Structure, Dynamics, Function and Disease
Fuchs, E., & Weber, K. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.002021 · Cited by 1,411
FOXOs: signalling integrators for homeostasis maintenance
Eijkelenboom, A., & Burgering, B. M. T. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3507 · Cited by 1,080
Regulation of Actin Assembly Associated With Protrusion and Adhesion in Cell Migration
Le Clainche, C., & Carlier, M.-F. (2008) · Physiological Reviews · doi:10.1152/physrev.00021.2007 · Cited by 849
McKeon, F. D., Kirschner, M. W., & Caput, D. (1986) · Nature · doi:10.1038/319463a0 · Cited by 826
Novel functions of vimentin in cell adhesion, migration, and signaling
Ivaska, J., Pallari, H.-M., Nevo, J., & Eriksson, J. E. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.03.040 · Cited by 785
Akt-Mediated Regulation of Autophagy and Tumorigenesis Through Beclin 1 Phosphorylation
Wang, R. C., Wei, Y., An, Z., Zou, Z., Xiao, G., Bhagat, G., White, M., Reichelt, J., & Levine, B. (2012) · Science · doi:10.1126/science.1225967 · Cited by 728
ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation
Yang, J.-Y., Zong, C. S., Xia, W., Yamaguchi, H., Ding, Q., Xie, X., Lang, J.-Y., Lai, C.-C., Chang, C.-J., Huang, W.-C., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1676 · Cited by 697
Vuoriluoto, K., Haugen, H., Kiviluoto, S., Mpindi, J.-P., Nevo, J., Gjerdrum, C., Tiron, C., Lorens, J. B., & Ivaska, J. (2011) · Oncogene · doi:10.1038/onc.2010.509 · Cited by 647
(2003) · PubMed · Cited by 624
Actin, microtubules, and vimentin intermediate filaments cooperate for elongation of invadopodia
Schoumacher, M., Goldman, R. D., Louvard, D., & Vignjevic, D. M. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200909113 · Cited by 507
Introducing intermediate filaments: from discovery to disease
Eriksson, J. E., Dechat, T., Grin, B., Helfand, B., Mendez, M., Pallari, H.-M., & Goldman, R. D. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38339 · Cited by 451
Invadopodia: Specialized Cell Structures for Cancer Invasion
Weaver, A. M. (2006) · Clinical & Experimental Metastasis · doi:10.1007/s10585-006-9014-1 · Cited by 424
Cytosolic proteins that specifically bind nuclear location signals are receptors for nuclear import
Adam, S. A., & Geracet, L. (1991) · Cell · doi:10.1016/0092-8674(91)90431-w · Cited by 387
Airway Epithelial Cells: Current Concepts and Challenges
Crystal, R. G., Randell, S. H., Engelhardt, J. F., Voynow, J., & Sunday, M. E. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200805-041hr · Cited by 375
Eriksson, J. E., He, T., Trejo-Skalli, A. V., Härmälä-Braskén, A.-S., Hellman, J., Chou, Y.-H., & Goldman, R. D. (2004) · Journal of Cell Science · doi:10.1242/jcs.00906 · Cited by 336
Vimentin contributes to human mammary epithelial cell migration
Gilles, C., Polette, M., Zahm, J.-M., Tournier, J.-M., Volders, L., Foidart, J.-M., & Birembaut, P. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.24.4615 · Cited by 314
Three-dimensional context regulation of metastasis
Erler, J. T., & Weaver, V. M. (2009) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9209-8 · Cited by 313
14-3-3 proteins block apoptosis and differentially regulate MAPK cascades
Xing, H. (2000) · The EMBO Journal · doi:10.1093/emboj/19.3.349 · Cited by 285
Vimentin organization modulates the formation of lamellipodia
Helfand, B. T., Mendez, M. G., Murthy, S. N. P., Shumaker, D. K., Grin, B., Mahammad, S., Aebi, U., Wedig, T., Wu, Y. I., Hahn, K. M., et al. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-08-0699 · Cited by 268
Self-citation14-3-3 proteins as signaling integration points for cell cycle control and apoptosis
Gardino, A. K., & Yaffe, M. B. (2011) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2011.09.008 · Cited by 263
Keratin Intermediate Filament Structure
Steinert, P. M., Marekov, L. N., Fraser, R. D. B., & Parry, D. A. D. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1161 · Cited by 258
Vimentin is a novel AKT1 target mediating motility and invasion
Zhu, Q.-S., Rosenblatt, K., Huang, K.-L., Lahat, G., Brobey, R., Bolshakov, S., Nguyen, T., Ding, Z., Belousov, R., Bill, K., et al. (2011) · Oncogene · doi:10.1038/onc.2010.421 · Cited by 246
Association of Vimentin overexpression and hepatocellular carcinoma metastasis
Hu, L., Lau, S. H., Tzang, C.-H., Wen, J.-M., Wang, W., Xie, D., Huang, M., Wang, Y., Wu, M.-C., Huang, J.-F., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1206483 · Cited by 230
Structure, Function, and Dynamics of Keratin Intermediate Filaments
Steinert, P. M. (1993) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12475665 · Cited by 202
Bowden, E. T., Onikoyi, E., Slack, R., Myoui, A., Yoneda, T., Yamada, K. M., & Mueller, S. C. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.12.012 · Cited by 192
Sutherland, K. D., & Berns, A. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.05.002 · Cited by 176
Vimentin Binding to Phosphorylated Erk Sterically Hinders Enzymatic Dephosphorylation of the Kinase
Perlson, E., Michaelevski, I., Kowalsman, N., Ben-Yaakov, K., Shaked, M., Seger, R., Eisenstein, M., & Fainzilber, M. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.09.056 · Cited by 166
Hammerschmidt, S., & Wirtz, H. R. W. (2009) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2009.0809 · Cited by 161
Tzivion, G., Luo, Z., & Avruch, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001207200 · Cited by 150
Post-translational modification of 14-3-3 isoforms and regulation of cellular function
Aitken, A. (2011) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.08.003 · Cited by 138
Vimentin is sufficient and required for wound repair and remodeling in alveolar epithelial cells
Rogel, M. R., Soni, P. N., Troken, J. R., Sitikov, A. S., Bittar, H. E. T., & Ridge, K. M. (2011) · The FASEB Journal · doi:10.1096/fj.10-170795 · Cited by 131
Self-citationBimodal regulation of FoxO3 by AKT and 14-3-3
Dobson, M., Ramakrishnan, G., Ma, S., Kaplun, L., Balan, V., Fridman, R. A., & Tzivion, G. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.05.001 · Cited by 122
Tang, D. D., Bai, Y., & Gunst, S. J. (2005) · Biochemical Journal · doi:10.1042/bj20050065 · Cited by 109
Lilienbaum, A., & Paulin, D. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53979-x · Cited by 99
Functional Analysis and Growth Factor Regulation of the Human Vimentin Promoter
Rittling, S. R., & Baserga, R. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.11.3908 · Cited by 99
Paccione, R. J., Miyazaki, H., Patel, V., Waseem, A., Gutkind, J. S., Zehner, Z. E., & Yeudall, W. A. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0450 · Cited by 95
Wu, Y., Zhang, X., Salmon, M., Lin, X., & Zehner, Z. E. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.11.017 · Cited by 93
AP-1/jun binding sites mediate serum inducibility of the human vimentin promoter
Rittling, S. R., Coutinho, L., Amram, T., & Kolbe, M. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.4.1619 · Cited by 83
Sivaramakrishnan, S., Schneider, J. L., Sitikov, A. S., Goldman, R. D., & Ridge, K. M. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-10-1028 · Cited by 82
Self-citationRegulation of vimentin intermediate filaments in endothelial cells by hypoxia
Liu, T., Guevara, O. E., Warburton, R. R., Hill, N. S., Gaestel, M., & Kayyali, U. S. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00057.2010 · Cited by 73
Barberis, L., Pasquali, C., Bertschy‐Meier, D., Cuccurullo, A., Costa, C., Ambrogio, C., Vilbois, F., Chiarle, R., Wymann, M. P., Altruda, F., et al. (2009) · European Journal of Immunology · doi:10.1002/eji.200838884 · Cited by 72
Vimentin Regulates Scribble Activity by Protecting It from Proteasomal Degradation
Phua, D. C. Y., Humbert, P. O., & Hunziker, W. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-02-0199 · Cited by 68
Dubey, S., & Powell, C. A. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200902-0289up · Cited by 65
Maxwell, S. A., Cherry, E. M., & Bayless, K. J. (2011) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2010.551793 · Cited by 54
Cited by
Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements
Aggarwal, V., Tuli, H., Varol, A., Thakral, F., Yerer, M., Sak, K., Varol, M., Jain, A., Khan, M., & Sethi, G. (2019) · Biomolecules · doi:10.3390/biom9110735 · Cited by 1,221
MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance
Iqbal, M. A., Arora, S., Prakasam, G., Calin, G. A., & Syed, M. A. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.07.003 · Cited by 449
Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis
Usman, S., Waseem, N. H., Nguyen, T. K. N., Mohsin, S., Jamal, A., Teh, M.-T., & Waseem, A. (2021) · Cancers · doi:10.3390/cancers13194985 · Cited by 430
Twist1 Regulates Vimentin through Cul2 Circular RNA to Promote EMT in Hepatocellular Carcinoma
Meng, J., Chen, S., Han, J.-X., Qian, B., Wang, X.-R., Zhong, W.-L., Qin, Y., Zhang, H., Gao, W.-F., Lei, Y.-Y., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3009 · Cited by 342
Hypoxia-Induced Epithelial-Mesenchymal Transition in Cancers: HIF-1α and Beyond
Tam, S. Y., Wu, V. W. C., & Law, H. K. W. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00486 · Cited by 298
Metadata
- Authors
- Kidd, M. E., Shumaker, D. K., & Ridge, K. M.
- Venue
- American Journal of Respiratory Cell and Molecular Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-01
- Volume
- 50
- Issue
- 1
- Pages
- 1-6
- ISSN
- 1044-1549 (ISSN-L)
- 1535-4989
- OpenAlex
- W2132546029
- Cited by
- 330
- References
- 47
- FWCI
- 5.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.